Table of Content

1. Global Coronavirus COVID 19 Clinical Trial Overview

1.1 By Phase
1.2 By Company
1.3 By Country
1.4 By Drug Class


2. Research Phase - COVID 2019 Infections Clinical Pipeline

2.1 Cannabidiol Enriched Extract
2.2 Coronavirus Vaccine - Vaxil BioTherapeutics
2.3 ACE2
2.4 Small Molecule Based Therapeutics
2.5 SARS-CoV-2 Vaccine Therapeutics
2.6 Coronavirus Antibodies
2.7 Recombinant Vaccines
2.8 Recombinant Subunit Vaccine
2.9 Interferon Alpha Therapy
2.10 AdVac? and PER.C6? Based Coronavirus Vaccine
2.11 SARS-CoV-2 Vaccine – Codagenix
2.12 Coronavirus Vaccine - CureVac
2.13 Coronavirus Hybrid Vaccines
2.14 Nanoviricide? Technology
2.15 DNA Coronavirus Vaccine
2.16 FastPharming System? Based Viral
2.17 Coronavirus Neutralising Antibodies
2.18 Anti-Infective Antibody Therapeutics
2.19 Angiopoietin-Tie2 Signaling Targetting
2.20 Small interfering RNA Based Therapeutics
2.21 INO 4800
2.22 Modified Vaccinia Ankara-Virus-Like Particles Coronavirus Vaccine
2.23 Neutralising Antibody Therapeutics
2.24 mRNA 1273


3. Preclinical Phase - COVID 2019 Infections Clinical Pipeline

3.1 Rintatolimod
3.2 Matrix-M? Saponin-Based Adjuvant
3.3 Inactivated Coronavirus Virus Vaccine
3.4 Linear DNA Based Vaccine


4. Clinical Phase - COVID 2019 Infections Clinical Pipeline

4.1 ITMN-191


5. Phase-II - COVID 2019 Infections Clinical Pipeline

5.1 ASC 09F


6. Phase-III - COVID 2019 Infections Clinical Pipeline

6.1 GS 5734


7. Competitve Landscape

7.1 AIM ImmunoTech
7.2 Ascletis
7.3 Gilead Sciences
7.4 iBio Inc
7.5 Inovio Pharmaceuticals
7.6 LineaRx
7.7 Mannin Research
7.8 Moderna Therapeutics
7.9 NanoViricides
7.10 Novavax
7.11 Q BioMed
7.12 Sanofi Pasteur
7.13 Sirnaomics
7.14 Takis
7.15 WuXi Biologics



List of Figures


Figure 1-1: Global - Coronavirus COVID 19 Clinical Trials By Phase (Number), 2020
Figure 1-2: Global - Coronavirus COVID 19 Clinical Trials By Phase (%), 2020
Figure 1-3: Global - Coronavirus COVID 19 Clinical Trials By Drug Class (Number), 2020
Figure 1-4: Global - Coronavirus COVID 19 Clinical Trials By Country (Number), 2020
Figure 1-5: Global - Coronavirus COVID 19 Clinical Trials By Drug Class (Number), 2020